CatalystPit

VYGRVoyager Therapeutics, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $2.68 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$165.14M
RECENT INSIDER TRADES
  • 2026-04-03 · Sandrock Alfred (President and CEO) · SELL
  • 2026-04-03 · Shiferman Gregory L. (SVP and General Counsel) · OTHER
  • 2026-02-26 · Jorgensen Nathan D. (Chief Financial Officer) · SELL
  • 2026-02-26 · Sandrock Alfred (President and CEO) · SELL
  • 2026-02-26 · Carter Todd Alfred (Chief Scientific Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders148
Shares held43,988,039
Value$177.43M
Percent of shares outstanding71.39%
As of quarter end2026-06-30
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Voyager Therapeutics, Inc. (VYGR) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit